The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes

Molecular Medicine

Volumn 2, Issue 6, 1996, Pages 755-765

  Acosta, Juan A ^a   Benzaquen, Laura R ^b   Goldstein, Daniel J ^a   Tosteson, Magdalena T ^a   Halperin, José A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GAMMA INTERFERON; GROWTH FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; IODINE 125; POLYPEPTIDE;

ARTICLE; CELL MEMBRANE TRANSPORT; CELL PROLIFERATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE GHOST; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIPID VESICLE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0030448388     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401659     Document Type: Article

References (36)

1. Muesch A, Hartmann E, Rohde K, Rubartelli A, Sitia R, Rapoport TA. (1990) A novel pathway for secretory proteins. TIBS 15: 86-88.
2. Barondes SH, Cooper DNW. (1990) Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol. 10: 1681-1691.
3. McNeil PL, Muthukrishanan L, Warder E, D'Amore PA. (1989) Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 109: 811-822.
4. Morgan BP. (1990) Complement: Clinical Aspects and Relevance to Disease. Academic Press, London.
5. Bhakdi S, Tranum-Jensen J. (1991) Complement lysis: A hole is a hole. Immunol. Today 12: 318-320.
6. Liszewski MK, Farries TC, Lublin, DM, Rooney IA, Atkinson JP. (1996) Control of the Complement System. Adv. Immunol. 61: 201-283.
7. Lublin DM, Atkinson JP. (1989) Decay-accelerating factor, biochemistry, molecular biology and function. Annu. Rev. Immunol. 7: 35-58.
8. Davies A, Simmons L, Hale G, et al. (1989) CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170: 637-654.
9. Lachmann PJ. (1991) The control of Homologous Lysis. Immunol. Today 12: 312-315.
10. Giavedoni EB, Chow YM, Dalmasso AP. (1979) The functional size of the primary complement lesion in resealed erythrocyte membrane ghosts. J. Immunol. 122: 240-244.
11. Ramm LE, Mayer MM. (1980) Life-span and size of the trans-membrane channel formed by large doses of complement. J. Immunol. 124: 2281-2287.
12. Malinski J, Nelsestuen G. (1989) Membrane permeability to macromolecules mediated by the membrane attack complex. Biochemistry 28: 61-70.
13. Benzaquen LR, Nicholson-Weller A, Halperin JA. (1994) Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179: 985-992.
14. Halperin JA, Taratuska A, Nicholson-Weller A. (1993) Terminal complement complex C5b-90 stimulates mitogenesis in 3T3 cells. J. Clin. Invest. 91: 1974-1978.
15. Bjerrum PJ. (1979) Hemoglobin-depleted human erythrocyte ghosts: characterization of morphology and transport functions. J. Membr. Biol. 48: 43-67.
16. MacDonald RC, MacDonald RI, Menco BPM, Takeshita K, Subbarao NK, Hu L-R. (1991) Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta 1061: 297-303.
17. Halperin JA, Nicholson-Weller A, Brugnara C, Tosteson DC. (1988) Complement induces a transient increase in membrane permeability in unlysed erythrocytes. J. Clin. Invest. 82: 594-600.
18. 111indium as indicators of endothelial cell injury. Lab. Invest. 57: 578-584.
19. Sauer H, Pratsch L, Tschopp J, Bhakdi S, Peters R. (1991) Functional size of complement and perform pores compared by confocal laser scanning microscopy and fluorescence microphotolysis. Biochim. Biophys. Acta 1063: 137-146.
20. Ramm LE, Whitlow MB, Mayer MM. (1982) Size of the transmembrane channels produced by complement proteins C5b-8. J. Immunol. 129: 1143-1146.
21. Zhang J, Cousens LS, Barr PJ, Sprang SR. (1991) Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β. Proc. Natl. Acad. Sci. U.S.A. 88: 3446-3450.
22. Ealick SE, Cook S, Vijak-Kumar S, et al. (1991) Three-dimensional structure of recombinant human interferon gamma. Science 252: 698-702.
23. Morgan BP. (1995) Physiology and pathophysiology of complement: Progress and trends. Crit. Rev. Clin. Lab. Sci. 32: 265-298.
24. Cybulsky AV, Monge JC, Papillon J, McTavish AJ. (1995) Complement C5b-9 activates cytosolic phospholipase A2 in glomerular epithelial cells. Am. J. Physiol. 269: F739-F749.
25. ++ in complement membrane attack. Cell Calcium 7: 399-411.
26. Morgan BP. (1989) Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects. Biochem. J. 264: 1-14.
27. Baldwin III WM, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. (1995) Complement in organ transplantation. Transplantation 59: 797-808.
28. Rosen RD. (1993) Complement activation in cardiac disease. In: Curtis MJ (ed). Immunopharmamlogy of the Heart. Academic Press, London, pp. 75-86.
29. Stahl GL, Reenstra WR, Frendl G. (1995) Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ. Res. 76: 575-583.
30. Falk RJ, Sisson SP, Dalmasso AP, Kim Y, Michael AF, Vernier RL. (1987) Ultrastructural localisation of the membrane attack complex of complement in human renal tissues. Am. J. Kidney Dis. 9: 121-128.
31. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D, Bowyer D. (1996) Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 16: 673-677.
32. Sauer H, Pratsch L, Fritzsch G, Bhakdi S, Peters R. (1991) Complement pore genesis observed in erythrocyte membranes by fluorescence microscopic single-channel recording. Biochem. J. 276: 395-399.
33. Simone CB, Henkart P. (1982) Inhibition of marker influx into complement-treated resealed erythrocyte ghosts by anti-C5. J. Immunol. 128: 1168-1175.
34. Sims PJ, Lauf PK. (1978) Steady-state analysis of tracer exchange across the C5b-9 complement lesion in a biological membrane. Proc. Natl. Acad. Sci. U.S.A. 75: 5669-5673.
35. Michaelis DW, Abramovitz AS, Hammer CH, Mayer MM. (1976) Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement. Proc. Natl. Acad. Sci. U.S.A. 73: 2852-2856.
36. Carney DF, Koski CL, Shin ML. (1985) Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5h-7 or C5h-8 a mixture of C5h-8 with a limited number of C5b-9. J. Biol. Chem. 134: 1804-1809.